CNTG - Centogene N.V.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Centogene N.V.

Am Strande 7
Rostock 18055
49 381 8011 3400

IndustryDiagnostics & Research
Full Time Employees350

Key Executives

NameTitlePayExercisedYear Born
Prof. Arndt RolfsFounder, CEO, Chief Medical Officer & Member of Management BoardN/AN/A1959
Mr. Richard StoffelenCFO & Member of Management BoardN/AN/A1967
Dr. Dirk H. EhlersCOO, Pres of Clinical Diagnostics & Member of Management BoardN/AN/A1961
Dr. Volkmar Weckesser Ph.D.Chief Information Officer & Member of Management BoardN/AN/A1967
Mr. Robert W. de DeugdSr. VP of Sales & Member of Management BoardN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Centogene B.V. operates as a commercial-stage rare disease company worldwide. It focuses on transforming clinical and genetic data into medical solutions for patients, physicians, and pharmaceutical companies. The company develops rare disease platform, a data repository, which includes epidemiologic, phenotypic, and heterogenetic data that enhances methods for identifying and monitoring rare hereditary diseases and provide solutions that accelerate the development of orphan drugs. It operates through two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment offers various services, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. The Diagnostics segment provides genetic sequencing and diagnostics services to physicians, laboratories, or hospitals directly or through distributors. Centogene B.V. was founded in 2006 and is headquartered in Rostock, Germany.

Corporate Governance

Centogene N.V.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.